RCM
AEON.WS

Robinson Capital Management’s AEON Biopharma Inc AEON.WS Stock Holding History

Robinson Capital Management’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-700
Closed -$735 – 234
2024
Q1 		$735 Sell
700
-216
-24% -$132 ﹤0.01% 172
2023
Q4 		$92 Sell
916
-104
-10% -$8 ﹤0.01% 198
2023
Q3 		$123 Sell
1,020
-2,206
-68% -$313 ﹤0.01% 216
2023
Q2 		$221 Buy
3,226
+1,598
+98% +$120 ﹤0.01% 232
2023
Q1 		$77 Hold
1,628
– – ﹤0.01% 284
2022
Q4 		$81 Buy
1,628
+1
+0.1% – ﹤0.01% 321
2022
Q3 		$0 Hold
1,627
– – ﹤0.01% 343
2022
Q2 		$0 Buy
1,627
+285
+21% +$60 ﹤0.01% 348
2022
Q1 		$0 Hold
1,342
– – ﹤0.01% 268
2021
Q4 		$1K Buy
+1,342
New +$742 ﹤0.01% 216

Robinson Capital Management's AEON.WS Position: Q2 2024 in Review

Robinson Capital Management sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 700 shares — an estimated $735 sold.

Robinson Capital Management first reported a position in AEON.WS in Q4 2021 and held it in 10 quarters. The position peaked at $1K in Q4 2021. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

  • Robinson Capital Management reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
  • Robinson Capital Management sold 700 AEON Biopharma Inc shares in Q2 2024, an estimated $735.
  • Robinson Capital Management first reported a position in AEON Biopharma Inc in Q4 2021 and held it in 10 quarters.
  • Robinson Capital Management's AEON Biopharma Inc position peaked at $1K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on Robinson Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.